We are live on
!
Find out more
ACM
Ativo Capital Management Portfolio holdings
AUM
$131M
1-Year Est. Return
19.64%
This Fund
S&P 500
This Quarter
Est. Return
+2.66%
1 Year Est. Return
+19.64%
3 Year Est. Return
+63.82%
5 Year Est. Return
+77.33%
10 Year Est. Return
+481.29%
AUM
$424M
AUM Growth
-$8.66M
(-2%)
Cap. Flow
-$12.2M
Cap. Flow
% of AUM
-2.87%
Top 10 Holdings %
Top 10 Hldgs %
23.3%
Holding
241
New
25
Increased
37
Reduced
68
Closed
21
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
SAP
SAP
|
+$3.12M |
| 2 |
Exelon
EXC
|
+$3.04M |
| 3 |
Aon
AON
|
+$2.98M |
| 4 |
DFS
Discover Financial Services
DFS
|
+$2.6M |
| 5 |
Sabesp
SBS
|
+$2.45M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
TARO
Taro Pharmaceutical Industries Ltd.
TARO
|
+$8.7M |
| 2 |
Korea Electric Power
KEP
|
+$3.75M |
| 3 |
Thermo Fisher Scientific
TMO
|
+$3.3M |
| 4 |
Unilever
UL
|
+$2.64M |
| 5 |
Alibaba
BABA
|
+$2.49M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 30.17% |
| 2 | Financials | 14.58% |
| 3 | Industrials | 12.4% |
| 4 | Consumer Discretionary | 10.3% |
| 5 | Healthcare | 8.59% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
226
Prudential
PUK
$35.1B
| – | – |
-7,217
| Closed | -$250K |
|
227
Smith & Nephew
SNN
$12.6B
| – | – |
-6,150
| Closed | -$202K |
|
|
228
Thermo Fisher Scientific
TMO
$222B
| – | – |
-20,725
| Closed | -$3.3M |
|
229
Travelers Companies
TRV
$78.3B
| – | – |
-11,533
| Closed | -$1.32M |
|
|
230
Unilever
UL
$135B
| – | – |
-49,439
| Closed | -$2.64M |
|
231
VeriSign
VRSN
$26.5B
| – | – |
-17,771
| Closed | -$1.39M |
|
232
Wipro
WIT
$19.7B
| – | – |
-614,475
| Closed | -$1.12M |
|
233
WSFS Financial
WSFS
$4.12B
| – | – |
-20,006
| Closed | -$730K |
|
|
TARO
234
DELISTED
Taro Pharmaceutical Industries Ltd.
TARO
| – | – |
-78,727
| Closed | -$8.7M |
|
|
NPTN
235
DELISTED
NEOPHOTONICS CORP
NPTN
| – | – |
-56,320
| Closed | -$920K |
|
|
LABL
236
DELISTED
Multi-Color Corp
LABL
| – | – |
-12,048
| Closed | -$795K |
|
Similar funds
EIM
CIP
AC
ADEF
EWP
OIM
EPI
WM
Ativo Capital Management's Q4 2016 Portfolio in Review
As of Q4 2016, Ativo Capital Management held 241 positions worth $424M, down 2% from $433M the previous quarter. Its ten largest holdings account for 23% of the portfolio.
Ativo Capital Management's Q4 2016 filing shows 25 new, 37 increased, 68 reduced and 21 closed positions. Its largest new stake was Exelon: 128,369 shares worth $3.25M. The largest sale was Taro Pharmaceutical Industries Ltd., an estimated $8.7M.
By sector, the portfolio is most concentrated in Technology at 30% of assets, up from 29% a quarter earlier, followed by Financials and Industrials.
- Ativo Capital Management's largest Q4 2016 buy was Exelon: 128,369 shares worth $3.25M.
- Ativo Capital Management added most to SAP in Q4 2016, an estimated $3.12M increase.
- Ativo Capital Management's biggest Q4 2016 reduction was Alibaba, cutting an estimated $2.49M.
- Ativo Capital Management fully exited Taro Pharmaceutical Industries Ltd. in Q4 2016, selling an estimated $8.7M.
- Ativo Capital Management's ten largest holdings make up 23% of its $424M portfolio in Q4 2016.
- Ativo Capital Management opened 25 new positions and closed 21 in Q4 2016.
- Ativo Capital Management's portfolio value fell 2% quarter-over-quarter to $424M.
Based on Ativo Capital Management's 13F filing for Q4 2016, filed 13 Feb 2017.